$AITX
Artificial Intelligence Technology Solutions Inc. Stock $aitx

$aitx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224021634 Filed on May 28, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$1.183M	$859.0K	$2.228M
YoY Change	207.05%	210.2%	67.24%
Cost Of Revenue	$295.6K	$814.7K	$1.131M
YoY Change	223.02%	263.4%	66.81%
Gross Profit	$887.2K	$44.35K	$1.096M
YoY Change	202.08%	-15.91%	67.68%
Gross Profit Margin	75.01%	5.16%	49.22%
Selling, General & Admin	$2.782M	$4.173M	$10.79M
YoY Change	27.45%	82.72%	16.72%
% of Gross Profit	313.59%	9408.84%	983.71%
Research & Development	$640.7K	$634.7K	$2.878M
YoY Change	-28.15%	-23.03%	-20.61%
% of Gross Profit	72.22%	1431.12%	262.49%
Depreciation & Amortization	$297.5K	$279.3K	$854.0K
YoY Change	77.18%	91.99%	78.63%
% of Gross Profit	33.54%	629.76%	77.89%
Operating Expenses	$3.720M	$5.087M	$15.09M
YoY Change	14.73%	56.33%	13.05%
Operating Profit	-$2.833M	-$5.042M	-$13.99M
YoY Change	-3.92%	57.52%	10.23%
Interest Expense	-$1.361M	-$1.817M	$6.758M
YoY Change	-15.26%	-8.14%	24.54%
% of Operating Profit
Other Income/Expense, Net	-$1.361M		-$6.719M
YoY Change	-15.26%		24.0%
Pretax Income	-$4.194M	-$7.427M	-$20.71M
YoY Change	-7.92%	43.41%	14.35%
Income Tax
% Of Pretax Income
Net Earnings	-$4.194M	-$7.427M	-$20.71M
YoY Change	-7.92%	43.41%	14.35%
Net Earnings / Revenue	-354.61%	-864.64%	-929.66%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	10.32B shares	8.355B shares	7.081B shares
Diluted Shares Outstanding	9.882B shares		7.081B shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$193.1K	$105.9K	$105.9K
YoY Change	-32.76%	-88.73%	-88.73%
Cash & Equivalents	$193.1K	$105.9K
Short-Term Investments
Other Short-Term Assets	$454.2K	$623.0K	$623.0K
YoY Change	-12.91%	4.47%	4.47%
Inventory	$1.830M	$2.132M	$2.132M
Prepaid Expenses	$454.2K	$623.0K
Receivables	$616.5K	$756.1K	$756.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.094M	$3.617M	$3.617M
YoY Change	15.03%	5.16%	5.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$278.9K	$268.1K	$3.887M
YoY Change	-90.82%	-15.14%	40.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$65.88K	$65.88K	$65.88K
YoY Change	-7.52%	-7.52%	-7.52%
Other Assets
YoY Change
Total Long-Term Assets	$4.832M	$3.980M	$3.980M
YoY Change	53.99%	39.27%	39.27%
TOTAL ASSETS
Total Short-Term Assets	$3.094M	$3.617M	$3.617M
Total Long-Term Assets	$4.832M	$3.980M	$3.980M
Total Assets	$7.926M	$7.597M	$7.597M
YoY Change	36.0%	20.64%	20.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.012M	$2.033M	$2.033M
YoY Change	50.57%	51.31%	51.31%
Accrued Expenses	$7.710M	$5.216M	$5.216M
YoY Change	54.64%	73.3%	73.3%
Deferred Revenue	$62.23K	$73.70K
YoY Change	70.69%	644.46%
Short-Term Debt	$1.594K	$1.594K	$0.00
YoY Change		0.0%
Long-Term Debt Due	$17.62M	$13.88M	$13.49M
YoY Change	6.77%	36.56%	32.7%
Total Short-Term Liabilities	$28.75M	$21.72M	$21.72M
YoY Change	17.3%	35.3%	35.3%
LONG-TERM LIABILITIES
Long-Term Debt	$14.96M	$14.80M	$14.80M
YoY Change	51.36%	-4.86%	-4.86%
Other Long-Term Liabilities	$9.869M	$11.28M	$11.28M
YoY Change	79.01%	72.61%	72.61%
Total Long-Term Liabilities	$24.83M	$26.08M	$26.08M
YoY Change	61.26%	18.06%	18.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.75M	$21.72M	$21.72M
Total Long-Term Liabilities	$24.83M	$26.08M	$26.08M
Total Liabilities	$53.58M	$47.80M	$47.80M
YoY Change	34.26%	25.32%	25.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.4M	-$133.0M
YoY Change	21.02%	18.45%
Common Stock	$103.2K	$92.39K
YoY Change	68.34%	57.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$45.91M	-$40.20M	-$40.20M
YoY Change
Total Liabilities & Shareholders Equity	$7.926M	$7.597M	$7.597M
YoY Change	36.0%	20.64%	20.64%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$4.194M	-$7.427M	-$20.71M
YoY Change	-7.92%	43.41%	14.35%
Depreciation, Depletion And Amortization	$297.5K	$279.3K	$854.0K
YoY Change	77.18%	91.99%	78.63%
Cash From Operating Activities	-$3.046M	-$3.573M	-$12.95M
YoY Change	1.83%	32.63%	2.98%
INVESTING ACTIVITIES
Capital Expenditures	$19.13K	$8.270K	$22.17K
YoY Change	452.95%	-79.73%	-91.42%
Acquisitions
YoY Change
Other Investing Activities		$22.50K	$26.36K
YoY Change		-145.0%	-152.72%
Cash From Investing Activities	-$21.73K	$14.23K	$4.194K
YoY Change	527.98%	-115.67%	-101.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.155M	3.568M	$12.11M
YoY Change	34.71%	18.48%	31.99%
NET CHANGE
Cash From Operating Activities	-$3.046M	-3.573M	-$12.95M
Cash From Investing Activities	-$21.73K	14.23K	$4.194K
Cash From Financing Activities	$3.155M	3.568M	$12.11M
Net Change In Cash	$87.18K	8.450K	-$833.8K
YoY Change	-113.36%	-96.27%	-77.51%
FREE CASH FLOW
Cash From Operating Activities	-$3.046M	-$3.573M	-$12.95M
Capital Expenditures	$19.13K	$8.270K	$22.17K
Free Cash Flow	-$3.065M	-$3.582M	-$12.97M
YoY Change	2.35%	30.96%	1.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5367805	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	AITX	Impairment On Revenue Earning Devices ImpairmentOnRevenueEarningDevices		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023	AITX	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2023	AITX	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2023	AITX	Penalty Shares Issued Pursuant To A Share Purchase Agreement PenaltySharesIssuedPursuantToASharePurchaseAgreement		usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023	AITX	Impairment On Revenue Earning Devices ImpairmentOnRevenueEarningDevices		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
CY2023	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
CY2024	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2023	AITX	Reimbursement Of Security Deposit ReimbursementOfSecurityDeposit		usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023	AITX	Net Borrowings Loan Payablerelated Party NetBorrowingsLoanPayablerelatedParty		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	AITX	Right Of Use Asset For Operating Lease Liability RightOfUseAssetForOperatingLeaseLiability		usd
CY2023	AITX	Proceeds Of Fixed Asset Disposition To Loan Payable Related Party ProceedsOfFixedAssetDispositionToLoanPayableRelatedParty		usd
CY2023	AITX	Shares Issued For Service SharesIssuedForService		usd
CY2023	AITX	Deferred Compensation DeferredCompensation		usd
CY2023	AITX	Series F Warrants Issued Along With Debt SeriesFWarrantsIssuedAlongWithDebt		usd
CY2024	AITX	Exchange Of Common Share Warrants For Debt ExchangeOfCommonShareWarrantsForDebt		usd
CY2024	AITX	Refund On Abandoned Trademarks RefundOnAbandonedTrademarks		usd
CY2024	AITX	Penalty Shares Pursuant To Share Purchase Agreement PenaltySharesPursuantToSharePurchaseAgreement		usd
CY2024	AITX	Exercise Of Warrants ExerciseOfWarrants		usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Adjusted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdjustedWeightedAverageExercisePrice
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedWeightedAverageRemainingTerm
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageRemainingTerm
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageRemainingTerm
CY2024	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2024Q1	AITX	Deferred Tax Liabilities Deferred Revenue DeferredTaxLiabilitiesDeferredRevenue		usd
CY2023Q1	AITX	Deferred Tax Liabilities Deferred Revenue DeferredTaxLiabilitiesDeferredRevenue		usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-29
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Security12g Title Security12gTitle	Common stock, $0.00001 par value
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	37637910	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10318917383	shares
CY2024	dei	Auditor Name AuditorName	L J Soldinger Associates, LLC
CY2024	dei	Auditor Location AuditorLocation	Deer Park, Illinois
CY2024	dei	Auditor Firm AuditorFirmId	318
CY2024Q1	us-gaap	Cash Cash	105926	usd
CY2023Q1	us-gaap	Cash Cash	939759	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	756084	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	265024	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2131599	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1637899	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	622957	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	596310	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3616566	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	3438992	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1139188	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1208440	usd
CY2024Q1	AITX	Accumulated Depreciation Revenue Earning Devices AccumulatedDepreciationRevenueEarningDevices	952844	usd
CY2023Q1	AITX	Accumulated Depreciation Revenue Earning Devices AccumulatedDepreciationRevenueEarningDevices	779839	usd
CY2024Q1	AITX	Revenue Earning Robots Net Of Accumulated Depreciation RevenueEarningRobotsNetOfAccumulatedDepreciation	2480002	usd
CY2023Q1	AITX	Revenue Earning Robots Net Of Accumulated Depreciation RevenueEarningRobotsNetOfAccumulatedDepreciation	1235219	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	349878	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182002	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	268075	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	315888	usd
CY2024Q1	AITX	Trademarks Trademarks	27080	usd
CY2023Q1	AITX	Trademarks Trademarks	27080	usd
CY2024Q1	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	50000	usd
CY2023Q1	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	50000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	15880	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	21239	usd
CY2024Q1	us-gaap	Assets Assets	7596791	usd
CY2023Q1	us-gaap	Assets Assets	6296858	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2032707	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1343379	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1594	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1594	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	73702	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9900	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	237653	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	248670	usd
CY2024Q1	AITX	Current Portion Of Deferred Variable Payment Obligation CurrentPortionOfDeferredVariablePaymentObligation	904377	usd
CY2023Q1	AITX	Current Portion Of Deferred Variable Payment Obligation CurrentPortionOfDeferredVariablePaymentObligation	542177	usd
CY2024Q1	AITX	Loan Payable Related Party LoanPayableRelatedParty	257438	usd
CY2023Q1	AITX	Loan Payable Related Party LoanPayableRelatedParty	206516	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	538767	usd
CY2024Q1	AITX	Discount Of Current Portion Of Loans Payable DiscountOfCurrentPortionOfLoansPayable	688598	usd
CY2023Q1	AITX	Discount Of Current Portion Of Loans Payable DiscountOfCurrentPortionOfLoansPayable	1651597	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	13190882	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	9918389	usd
CY2024Q1	AITX	Vehicle Loan Current Portion VehicleLoanCurrentPortion	38522	usd
CY2023Q1	AITX	Vehicle Loan Current Portion VehicleLoanCurrentPortion	38522	usd
CY2024Q1	AITX	Accrued Interest Payable Current AccruedInterestPayableCurrent	4440009	usd
CY2023Q1	AITX	Accrued Interest Payable Current AccruedInterestPayableCurrent	2761446	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21715651	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15070593	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	889360	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	950541	usd
CY2024Q1	AITX	Discount Of Loans Payable DiscountOfLoansPayable	4118332	usd
CY2023Q1	AITX	Discount Of Loans Payable DiscountOfLoansPayable	4130291	usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	14798532	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	15554069	usd
CY2024Q1	AITX	Deferred Variable Payment Obligation DeferredVariablePaymentObligation	2525000	usd
CY2023Q1	AITX	Deferred Variable Payment Obligation DeferredVariablePaymentObligation	2525000	usd
CY2024Q1	AITX	Incentive Compensation Plan Payable IncentiveCompensationPlanPayable	2500000	usd
CY2023Q1	AITX	Incentive Compensation Plan Payable IncentiveCompensationPlanPayable	979000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3060656	usd
CY2024Q1	us-gaap	Liabilities Liabilities	47796348	usd
CY2023Q1	us-gaap	Liabilities Liabilities	38139859	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15535000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15535000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	AITX	Cumulative Dividend Payable Percentage CumulativeDividendPayablePercentage	0.08	pure
CY2023Q1	AITX	Cumulative Dividend Payable Percentage CumulativeDividendPayablePercentage	0.08	pure
CY2024Q1	AITX	Cumulative Dividend Payable CumulativeDividendPayable	1200	usd
CY2023Q1	AITX	Cumulative Dividend Payable CumulativeDividendPayable	1200	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9238750958	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9238750958	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5848741599	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5848741599	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	58489	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80247252	usd
CY2023Q1	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	99086	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112253711	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-31843001	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6296858	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	1131102	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	678073	usd
CY2024	us-gaap	Gross Profit GrossProfit	1096457	usd
CY2023	us-gaap	Gross Profit GrossProfit	653883	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2878134	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3625468	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8980709	usd
CY2023	us-gaap	Depreciation Depreciation	478115	usd
CY2024	AITX	Impairment On Revenue Earning Devices ImpairmentOnRevenueEarningDevices	584177	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	260406	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	260271	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	16426	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	15085869	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	13344563	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-13989412	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-12690680	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3595	usd
CY2024	us-gaap	Interest Expense InterestExpense	6758044	usd
CY2023	us-gaap	Interest Expense InterestExpense	5426364	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	38740	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3992	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6719304	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5418777	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20708716	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18109457	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7080914317	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7080914317	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5091857082	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5091857082	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-20976357	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	447858	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7771169	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	108378210	usd
CY2023	AITX	Relative Fair Value Of Series F Warrants Issued With Debt RelativeFairValueOfSeriesFWarrantsIssuedWithDebt	1201128	usd
CY2023	AITX	Relative Fair Value Of Warrants Issued With Debt RelativeFairValueOfWarrantsIssuedWithDebt	990467	usd
CY2023	AITX	Warrants Cancelled For Debt Issuance WarrantsCancelledForDebtIssuance	955000000	shares
CY2023	AITX	Fair Value Of Warrants Cancelled For Debt Issuance FairValueOfWarrantsCancelledForDebtIssuance	-2960500	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	118500	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	122050	usd
CY2023	AITX	Rounding Shares RoundingShares	-1	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18109457	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-31843001	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-31843001	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-31843001	usd
CY2024	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	457060	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10825895	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10825895	usd
CY2024	AITX	Relative Fair Value Of Series F Warrants Issued With Debt RelativeFairValueOfSeriesFWarrantsIssuedWithDebt	1209206	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	44460	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	272599	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20708716	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-40199557	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-40199557	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20708716	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18109457	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	854047	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	478115	usd
CY2024	AITX	Impairment On Revenue Earning Devices ImpairmentOnRevenueEarningDevices	584177	usd
CY2024	AITX	Inventory Provision InventoryProvision	437820	usd
CY2023	AITX	Inventory Provision InventoryProvision	130000	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	16426	usd
CY2024	AITX	Allowance For Loan And Leases Loss Recovery Of Bad Debts AllowanceForLoanAndLeasesLossRecoveryOfBadDebts	42892	usd
CY2023	AITX	Allowance For Loan And Leases Loss Recovery Of Bad Debts AllowanceForLoanAndLeasesLossRecoveryOfBadDebts	45110	usd
CY2024	AITX	Reduction Of Right Of Use Asset ReductionOfRightOfUseAsset	120131	usd
CY2023	AITX	Reduction Of Right Of Use Asset ReductionOfRightOfUseAsset	112396	usd
CY2024	AITX	Accretion Of Lease Liability AccretionOfLeaseLiability	130020	usd
CY2023	AITX	Accretion Of Lease Liability AccretionOfLeaseLiability	141631	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1793599	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	740050	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3595	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2384163	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1980033	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	38740	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3992	usd
CY2024	AITX	Increase In Related Party Accrued Payroll And Interest IncreaseInRelatedPartyAccruedPayrollAndInterest	105101	usd
CY2023	AITX	Increase In Related Party Accrued Payroll And Interest IncreaseInRelatedPartyAccruedPayrollAndInterest	12960	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	533952	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-119335	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	29591	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	141734	usd
CY2024	AITX	Robot Parts Inventory RobotPartsInventory	3549121	usd
CY2023	AITX	Robot Parts Inventory RobotPartsInventory	1161047	usd
CY2024	AITX	Increase Decrease In Accounts Payables And Accrued Liabilities IncreaseDecreaseInAccountsPayablesAndAccruedLiabilities	1294286	usd
CY2023	AITX	Increase Decrease In Accounts Payables And Accrued Liabilities IncreaseDecreaseInAccountsPayablesAndAccruedLiabilities	374529	usd
CY2024	AITX	Increase Decrease In Customer Discounts IncreaseDecreaseInCustomerDiscounts	63802	usd
CY2023	AITX	Increase Decrease In Customer Discounts IncreaseDecreaseInCustomerDiscounts	-100	usd
CY2024	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-233147	usd
CY2023	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-254028	usd
CY2024	AITX	Increase Decrease In Current Portion Of Deferred Variable Payment Obligation IncreaseDecreaseInCurrentPortionOfDeferredVariablePaymentObligation	362200	usd
CY2023	AITX	Increase Decrease In Current Portion Of Deferred Variable Payment Obligation IncreaseDecreaseInCurrentPortionOfDeferredVariablePaymentObligation	216577	usd
CY2024	AITX	Increase Decrease In Interest Payable IncreaseDecreaseInInterestPayable	3985712	usd
CY2023	AITX	Increase Decrease In Interest Payable IncreaseDecreaseInInterestPayable	2745822	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12951743	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12577395	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22165	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	258402	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	50000	usd
CY2024	AITX	Reimbursement Of Security Deposit ReimbursementOfSecurityDeposit	-5359	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	21000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4194	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-308402	usd
CY2024	AITX	Share Proceeds Net Of Issuance Costs ShareProceedsNetOfIssuanceCosts	10825895	usd
CY2023	AITX	Share Proceeds Net Of Issuance Costs ShareProceedsNetOfIssuanceCosts	7771169	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	619250	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	750000	usd
CY2024	AITX	Net Borrowings Loan Payablerelated Party NetBorrowingsLoanPayablerelatedParty	54179	usd
CY2024	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1750000	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3300000	usd
CY2024	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	408000	usd
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1763009	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12113716	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9177410	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-833833	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3708387	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	939759	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4648146	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	105926	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	939759	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	17726	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	451192	usd
CY2024	AITX	Right Of Use Asset For Operating Lease Liability RightOfUseAssetForOperatingLeaseLiability	47934	usd
CY2024	AITX	Transfer From Device Parts Inventory To Revenue TransferFromDevicePartsInventoryToRevenue	-2291421	usd
CY2023	AITX	Transfer From Device Parts Inventory To Revenue TransferFromDevicePartsInventoryToRevenue	-932805	usd
CY2024	AITX	Proceeds Of Fixed Asset Disposition To Loan Payable Related Party ProceedsOfFixedAssetDispositionToLoanPayableRelatedParty	21000	usd
CY2024	AITX	Shares Issued For Service SharesIssuedForService	44460	usd
CY2024	AITX	Deferred Compensation DeferredCompensation	538767	usd
CY2024	AITX	Discount Added To Face Value Of Loans DiscountAddedToFaceValueOfLoans	-200000	usd
CY2023	AITX	Discount Added To Face Value Of Loans DiscountAddedToFaceValueOfLoans	-1797645	usd
CY2024	AITX	Series F Warrants Issued Along With Debt SeriesFWarrantsIssuedAlongWithDebt	1209206	usd
CY2023	AITX	Exchange Of Common Share Warrants For Debt ExchangeOfCommonShareWarrantsForDebt	3000000	usd
CY2023	AITX	Refund On Abandoned Trademarks RefundOnAbandonedTrademarks	1643	usd
CY2023	AITX	Penalty Shares Pursuant To Share Purchase Agreement PenaltySharesPursuantToSharePurchaseAgreement	171	usd
CY2023	AITX	Exercise Of Warrants ExerciseOfWarrants	453	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_z9vKutSyuqkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_829_zvlLiQqF4iah">GENERAL INFORMATION AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Artificial Intelligence Technology Solutions Inc. (formerly known as On the Move Systems Corp.) (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc. through the issuance of <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20170725__us-gaap--BusinessAcquisitionAxis__custom--RoboticAssistanceDevicesLLCMember_zUpHR89OzsUc" title="Common stock, issued">10,000</span> common shares to its sole shareholder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for <span id="xdx_902_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20170827__20170828__us-gaap--BusinessAcquisitionAxis__custom--RoboticAssistanceDevicesLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zmrCxTLzCxv2" title="Number of shares isuued under acquisition">3,350,000</span> shares of AITX Series E Preferred Stock and <span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20170827__20170828__us-gaap--BusinessAcquisitionAxis__custom--RoboticAssistanceDevicesLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zLy2ba1DwtIe" title="Number of shares isuued under acquisition">2,450</span> shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and AITX was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, in which AITX purchased all of the outstanding shares of capital stock of RAD. As a result, AITX’s business going forward will consist of one segment activity which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOING CONCERN</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended February 29, 2024, the Company had negative cash flow from operating activities of $<span id="xdx_904_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20230301__20240229_ze4MQ8ZfTwRj" title="Cash flow from operating activities">12,951,743</span>. As of February 29, 2024 the Company has an accumulated deficit of $<span id="xdx_904_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20240229_zS9uYaNQiAN4" title="Accumulated deficit">132,962,427</span> and negative working capital of $<span id="xdx_901_ecustom--WorkingCapital_iI_pp0p0_di_c20240229_zVrBU6X1THGl" title="Working capital">18,099,085</span>. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20230301__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z56EAPegQcRg" title="Purchase of common stock">30,000,000</span> of the Company’s common stock at a discount over a two-year period. There remains approximately $<span id="xdx_907_eus-gaap--CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount_iI_c20240229_zh9S94O8ThOa" title="Common stock net of discount">21</span> million left to issue under this arrangement.. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways : growing revenues ,through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12951743	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132962427	usd
CY2024Q1	AITX	Working Capital WorkingCapital	-18099085	usd
CY2024Q1	us-gaap	Common Stocks Including Additional Paid In Capital Net Of Discount CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount	21	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z1KCqoOZl9U5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zuOnsBGMe1wk">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to prepare financial statements in conformity with accounting principals generally accepted in the United States, management must make estimates , judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zro0Zk7ZRuA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zKiSxz89gzz1">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_ziKhxlDN0qu3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zQa8ikzCXJ26">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loans payable</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At February 29, 2024 there were $<span id="xdx_90D_eus-gaap--LoansPayable_iI_pp0p0_c20240229_zqmze0C7sXui" title="Loans payable">32,796,345</span> of loans payable, $<span id="xdx_907_eus-gaap--LoanPortfolioExpense_pp0p0_c20230301__20240229__srt--TitleOfIndividualAxis__srt--ControllerMember_zlv6wDuIF4Qc" title="Loans additions">28,540,506</span> or <span id="xdx_902_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240229__srt--TitleOfIndividualAxis__srt--ControllerMember_zCzZOJHKvvr6" title="Loans percentage">87%</span> of these loans to companies controlled by one individual. At February 28, 2023 there were $<span id="xdx_905_eus-gaap--LoansPayable_iI_pp0p0_c20230228_zcgaVLkANqD8" title="Loans payable">31,254,345</span> of loans payable, $<span id="xdx_90C_eus-gaap--LoanPortfolioExpense_pp0p0_c20220301__20230228__srt--TitleOfIndividualAxis__srt--ControllerMember_zRrqOiDZPy1f" title="Loans additions">26,540,506</span> or <span id="xdx_908_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_dp_uPure_c20230228__srt--TitleOfIndividualAxis__srt--ControllerMember_zrkZUngfS9D8" title="Loans percentage">85%</span> of these loans to companies controlled by one individual.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Loans Payable LoansPayable	32796345	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	31254345	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	68000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	959000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	195000	usd
CY2024Q1	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife	P48M
CY2024Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	0	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%
CY2024Q1	AITX	Incentives Compensation Plan Payable Revaluation Of Equity IncentivesCompensationPlanPayableRevaluationOfEquity	2500000	usd
CY2023Q1	AITX	Incentives Compensation Plan Payable Revaluation Of Equity IncentivesCompensationPlanPayableRevaluationOfEquity	979000	usd
CY2024	AITX	Revenue From Device Rental Activities RevenueFromDeviceRentalActivities	1626207	usd
CY2023	AITX	Revenue From Device Rental Activities RevenueFromDeviceRentalActivities	754126	usd
CY2024	AITX	Revenue From Direct Sales Of Goods And Services RevenueFromDirectSalesOfGoodsAndServices	601352	usd
CY2023	AITX	Revenue From Direct Sales Of Goods And Services RevenueFromDirectSalesOfGoodsAndServices	577830	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2227559	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1331956	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12M
CY2024Q1	AITX	Operating Lease Assets OperatingLeaseAssets	1139188	usd
CY2023Q1	AITX	Operating Lease Assets OperatingLeaseAssets	1208440	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	237653	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	248670	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	889360	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	950541	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1127013	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1199211	usd
CY2024	us-gaap	Payments For Rent PaymentsForRent	260406	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	260271	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	3432846	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	2015058	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	952844	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	779839	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2480002	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1235219	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	617953	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	497890	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	349878	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182002	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	268075	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	315888	usd
CY2024Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	4574	usd
CY2024	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	21000	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	16426	usd
CY2024Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	904377	usd
CY2024Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	542176	usd
CY2022Q1	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.06
CY2022	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingTerm	P2Y4M17D
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	542177	usd
CY2023Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	325600	usd
CY2021Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1925000	usd
CY2024	AITX	Deferred Payment Obligation Receive DeferredPaymentObligationReceive	0	usd
CY2023	AITX	Deferred Payment Obligation Receive DeferredPaymentObligationReceive	0	usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	54179	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2024	us-gaap	Interest And Debt Expense InterestAndDebtExpense	32468	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	15660	usd
CY2023Q4	AITX	Discretionary Compensation Amount DiscretionaryCompensationAmount	1000000	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	2810839	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	3578981	usd
CY2024	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	76532	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	76532	usd
CY2021Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	0	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	32796346	usd
CY2024Q1	AITX	Long Term Notes Payable Non Current LongTermNotesPayableNonCurrent	-13879479	usd
CY2024Q1	AITX	Discount On Long Term Notes Payable Non Current DiscountOnLongTermNotesPayableNonCurrent	-4118334	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	14798532	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	13879479	usd
CY2024Q1	AITX	Discount On Long Term Notes Payable Current DiscountOnLongTermNotesPayableCurrent	-688597	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	13190882	usd
CY2023Q1	AITX	Cumulative Dividend Payable Percentage CumulativeDividendPayablePercentage	0.08	pure
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	118500	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1216845661	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Adjusted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdjusted	66750000	shares
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Adjusted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdjustedWeightedAverageExercisePrice	0.011
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Adjusted Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdjustedWeightedAverageRemainingTerm	P1Y4M28D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	94000000	shares
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.01
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedWeightedAverageRemainingTerm	P4Y8M8D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	108378210	shares
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.011
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageRemainingTerm	P2Y5M8D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	955000000	shares
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice	0.008
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedWeightedAverageRemainingTerm	P1Y3M29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	314217451	shares
CY2023Q1	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.114
CY2023	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingTerm	P1Y11M12D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	13621790	shares
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice	0.01
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	300595661	shares
CY2024Q1	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.003
CY2024	AITX	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingTerm	P1Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2960500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	47000000	shares
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	393949	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1521000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	499500	usd
CY2024	AITX	Rent Expense And Operating Lease Cost RentExpenseAndOperatingLeaseCost	260406	usd
CY2023	AITX	Rent Expense And Operating Lease Cost RentExpenseAndOperatingLeaseCost	260271	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	237653	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	237653	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	225348	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	225348	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	223866	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	223866	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207558	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207558	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	207558	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	207558	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	449709	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	449709	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1551692	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	424679	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1127013	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20708716	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18109457	usd
CY2023	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	47075	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3595	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20708716	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18065977	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7080914317	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5091857082	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7080914317	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5091857082	shares
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32362953501	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	496942251	shares
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4349000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-994000	usd
CY2024	AITX	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	501000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	377000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4465000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3803000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-859400	usd
CY2023	AITX	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	415800	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	155400	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4091200	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17116115	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12651115	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17116115	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12651115	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	61973800	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	44448800	usd
CY2024	AITX	Operating Loss Carryforwards Expiration OperatingLossCarryforwardsExpiration	2030

Files In Submission

Name	View Source	Status
0001493152-24-021634-index-headers.html	Edgar Link	pending
0001493152-24-021634-index.html	Edgar Link	pending
0001493152-24-021634.txt	Edgar Link	pending
0001493152-24-021634-xbrl.zip	Edgar Link	pending
aitx-20240229.xsd	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
aitx-20240229_lab.xml	Edgar Link	unprocessable
aitx-20240229_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aitx-20240229_cal.xml	Edgar Link	unprocessable
aitx-20240229_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AITX
Artificial Intelligence Technology Solutions Inc. Stock $aitx

2024 Q2 Form 10-K Financial Statement

#000149315224021634 Filed on May 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AITX Artificial Intelligence Technology Solutions Inc. Stock $aitx

2024 Q2 Form 10-K Financial Statement

#000149315224021634 Filed on May 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AITX
Artificial Intelligence Technology Solutions Inc. Stock $aitx